Comparison of Rotational with Orbital Atherectomy During Percutaneous Coronary Intervention for Coronary Artery Calcification: A Systematic Review and Meta-Analysis.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
04 2020
Historique:
received: 25 03 2019
revised: 29 06 2019
accepted: 17 07 2019
pubmed: 5 8 2019
medline: 27 10 2020
entrez: 5 8 2019
Statut: ppublish

Résumé

Percutaneous coronary intervention (PCI) outcomes for patients with significant calcification have been consistently inferior compared to patients without significant calcification. Procedural success and long-term outcomes after PCI have been worse in patients with severe coronary calcium. A Bayesian meta-analysis of outcomes comparing rotational atherectomy (RA) with orbital atherectomy (OA) was performed. PubMed, Embase, and Cochrane Library databases were searched through 30th November 2018 and identified 4 observational studies. The primary end-point, Major Adverse Cardiac Event (MACE) composing of death, MI and stroke at 1 year was more likely with RA (OR = 1.61; 95% CI: 1.11-2.33; p = 0.01) as compared to OA. The driver of the difference in MACE between the two groups was a statistically significant difference in mortality favoring OA (OR = 4.65; 95% CI: 1.36-15.87; p = 0.01). Peri-procedural MI, the other component of the primary end-point was 1.3 times more likely in the RA arm (OR = 1.35; 95% CI 0.95-1.92; p-0.09) and was not statistically different between the groups. The odds of a vascular complication were not different in the two groups (OR = 1.26; 95% CI: 0.73-2.17; p = 0.41). In an adjusted Bayesian analysis, mortality (OR = 3.69; 95% CI: 0.30-38.51), MACE (OR = 1.68; 95% CI: 0.55-5.49), MI (OR = 1.42; 95% CI: 0.50-4.29) and dissections/perforations (OR = 0.38; 95% CI: 0.10-1.38) were not different in RA and OA groups. Our study is the first published Bayesian meta-analysis comparing MACE and peri-procedural outcomes in RA compared to OA. These findings lay the foundation for a randomized comparison between the two competing technologies.

Sections du résumé

BACKGROUND
Percutaneous coronary intervention (PCI) outcomes for patients with significant calcification have been consistently inferior compared to patients without significant calcification. Procedural success and long-term outcomes after PCI have been worse in patients with severe coronary calcium.
OBJECTIVE
A Bayesian meta-analysis of outcomes comparing rotational atherectomy (RA) with orbital atherectomy (OA) was performed.
METHODS
PubMed, Embase, and Cochrane Library databases were searched through 30th November 2018 and identified 4 observational studies.
RESULTS
The primary end-point, Major Adverse Cardiac Event (MACE) composing of death, MI and stroke at 1 year was more likely with RA (OR = 1.61; 95% CI: 1.11-2.33; p = 0.01) as compared to OA. The driver of the difference in MACE between the two groups was a statistically significant difference in mortality favoring OA (OR = 4.65; 95% CI: 1.36-15.87; p = 0.01). Peri-procedural MI, the other component of the primary end-point was 1.3 times more likely in the RA arm (OR = 1.35; 95% CI 0.95-1.92; p-0.09) and was not statistically different between the groups. The odds of a vascular complication were not different in the two groups (OR = 1.26; 95% CI: 0.73-2.17; p = 0.41). In an adjusted Bayesian analysis, mortality (OR = 3.69; 95% CI: 0.30-38.51), MACE (OR = 1.68; 95% CI: 0.55-5.49), MI (OR = 1.42; 95% CI: 0.50-4.29) and dissections/perforations (OR = 0.38; 95% CI: 0.10-1.38) were not different in RA and OA groups.
CONCLUSION
Our study is the first published Bayesian meta-analysis comparing MACE and peri-procedural outcomes in RA compared to OA. These findings lay the foundation for a randomized comparison between the two competing technologies.

Identifiants

pubmed: 31377129
pii: S1553-8389(19)30431-2
doi: 10.1016/j.carrev.2019.07.019
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

501-507

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors report no conflict of interest.

Auteurs

Abhishek C Sawant (AC)

Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA.

Hemang Panchal (H)

Division of Cardiology Mount Sinai Medical Center, Columbia University, Miami Beach, FL, USA.

Dhruvil Radadiya (D)

Department of Medicine, East Tennessee State University, Johnson City, TN, USA.

Alexander Pomakov (A)

Division of Cardiology, State University of New York at Buffalo, Buffalo, NY, USA.

Gary Tse (G)

Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong Special Administrative Region.

Tong Liu (T)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, People's Republic of China.

Srilekha Sridhara (S)

Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA.

Janelle Rodriguez (J)

Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA.

Meghana Prakash Hiriyur Prakash (MPH)

Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA.

Nidhi Kanwar (N)

Division of Cardiology, State University of New York at Buffalo, Buffalo, NY, USA.

Arnav Kumar (A)

Andreas Gruentzig Cardiovascular Center, Emory University School of Medicine, Atlanta, GA, USA.

Kinjal Banerjee (K)

Department of Medicine, Geisinger Commonwealth School of Medicine, Geisinger, PA, USA.

Philipp Wiesner (P)

Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA.

Ashish Pershad (A)

Division of Interventional Cardiology, Banner University Medical Center, Phoenix, AZ, USA. Electronic address: ashish.pershad@bannerhealth.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH